Skip to main content
  • Contact Us
  • Back to Homepage
  • follow us on linkedin
  • follow us on facebook
  • follow us on twitter
  • follow us on youtube
Marinus Pharmaceuticals
  • Investors & Media
    • News
    • Events & Presentations
    • Financials
      • Quarterly Results
      • Annual Reports
      • SEC Filings
      • Interactive Financials
      • Form 8937
    • Stock Information
      • Stock Details
      • Analyst Coverage
    • Governance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • ZTALMY Factsheet

Site Search

News

  • Investors & Media
    • News
    • Events & Presentations
    • Financials
      • Quarterly Results
      • Annual Reports
      • SEC Filings
      • Interactive Financials
      • Form 8937
    • Stock Information
      • Stock Details
      • Analyst Coverage
    • Governance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • ZTALMY Factsheet
Normal
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
12/03/2014
Marinus Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
11/13/2014
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2014 Financial Results
11/11/2014
Marinus Pharmaceuticals to Present at the Stifel Healthcare Conference
09/25/2014
Marinus Pharmaceuticals, Inc. to Present at the 21st Annual BioCentury Newsmakers Conference on Friday, September 26, 2014
09/02/2014
Marinus Pharmaceuticals, Inc. Announces Exercise of Over-Allotment Option in Public Offering of Common Stock
08/25/2014
Marinus Pharmaceuticals, Inc. to Ring the Opening Bell of the NASDAQ Stock Market
08/12/2014
Marinus Pharmaceuticals, Inc. Enters Into Use Agreement With CyDex Pharmaceuticals, Inc. for Use of Captisol(R) for Ganaxolone IV
07/31/2014
Marinus Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
01/09/2014
Marinus Pharmaceuticals Bolsters Its Board of Directors and Executive Management

Contact Us

Sasha Damouni Ellis
Vice President, Corporate Affairs & Investor Relations
Marinus Pharmaceuticals, Inc.

info@marinuspharma.com

Quick Links

  • SEC Filings
  • Investor FAQs

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Marinus Pharmaceuticals, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Marinus Pharmaceuticals to send you the requested Investor Email Alert updates.

* Required

*
*





Unsubscribe

Email Alert Sign Up Confirmation

Marinus Pharmaceuticals
  • Terms of Use
© Marinus Pharmaceuticals, Inc.
Powered By Q4 Inc. 5.95.0.14 (opens in new window)